---
title: "Hong Kong Stock Movement Update: Biopharmaceutical stocks rebound strongly, PEGBIO CO-B rises 23%, METASPACEX falls 15%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286734697.md"
description: "In the past hour, the Hong Kong stock market has shown a clear divergence, with the strong performance of the pharmaceutical sector attracting a significant inflow of funds, particularly in stocks like PEGBIO CO-B and BAO PHARMA-B, which have seen notable gains, indicating an increase in short-term enthusiasm. Meanwhile, technology stocks appear relatively weak, with the declines of METASPACEX and Yimu Group drawing market attention, suggesting a rapid switch of funds between different sectors. Overall volatility is high, and the sentiment of short-term traders is fluctuating, with a faster market rhythm. The stock with the largest movement in the past hour, PEGBIO CO-B, has surged by 23.15%, rapidly attracting funds under the influence of the pharmaceutical sector, leading to heightened short-term sentiment and drawing the attention of many investors. The strong performance of this stock seems to inject vitality into the entire sector, driving up other related stocks. Strong stocks include: 1. BAO PHARMA-B: up 18.49%, with continuous inflow of funds against the backdrop of increased market enthusiasm, showing impressive short-term performance. 2. XUANZHUBIO-B: up 16.00%, recent strong trends reflect market confidence in its future development. 3. Jingjiu Kangliao: up 15.87%, gaining favor from investors as the pharmaceutical sector becomes active. 4. Zhongke Group Holdings - New: up 15.38%, with significant short-term fund support amid high market sentiment. 5. Silu Di Pharmaceutical Co., Ltd.: up 15.12%, with the stock's rise reflecting optimistic expectations for the pharmaceutical industry"
datetime: "2026-05-18T08:00:08.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286734697.md)
  - [en](https://longbridge.com/en/news/286734697.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286734697.md)
---

# Hong Kong Stock Movement Update: Biopharmaceutical stocks rebound strongly, PEGBIO CO-B rises 23%, METASPACEX falls 15%

**Hong Kong Stock Market Overview in the Last Hour**

The overall market has shown a clear divergence, with the strong performance of the pharmaceutical sector attracting a significant inflow of funds, particularly in stocks like PEGBIO CO-B and BAO PHARMA-B, which have seen notable gains, indicating an increase in short-term enthusiasm. Meanwhile, technology stocks appear relatively weak, with the declines of METASPACEX and Yimu Group drawing market attention, suggesting a rapid switch of funds between different sectors. The overall volatility is considerable, and the sentiment of short-term traders is fluctuating, with a faster market rhythm.

**Stocks with the Most Significant Movements in the Last Hour**

PEGBIO CO-B has surged by 23.15%, driven by the pharmaceutical sector, with rapid fund inflow and heightened short-term sentiment, attracting the attention of many investors. The strong performance of this stock seems to inject vitality into the entire sector, boosting the rise of other related stocks.

**Strong Stocks**

1.  BAO PHARMA-B: Up 18.49%, with continuous fund inflow against the backdrop of increased market enthusiasm, showing impressive short-term performance.
    
2.  XUANZHUBIO-B: Up 16.00%, recent strong trends indicate market confidence in its future development.
    
3.  Jingjiu Kangliao: Up 15.87%, as the pharmaceutical sector becomes active, this stock has also gained favor among investors.
    
4.  Zhongke Group Holdings - New: Up 15.38%, with heightened market sentiment, the push from short-term funds is significant.
    
5.  Silu Di Pharmaceutical Co., Ltd.: Up 15.12%, the rise of this stock reflects the market's optimistic expectations for the pharmaceutical industry.
    
6.  Shenghong Technology: Up 10.82%, this stock shows a certain degree of resilience amid overall market fluctuations.
    

**Stocks Under Pressure**

1.  METASPACEX: Down 15.25%, lacking significant positive news recently, leading to fund outflows.
    
2.  Yimu Group: Down 15.24%, with weakening market sentiment, short-term funds are choosing to exit.
    
3.  China Star Group - 2000: Down 10.16%, in the overall market divergence, this stock's performance appears particularly weak

### Related Stocks

- [02565.HK](https://longbridge.com/en/quote/02565.HK.md)
- [02659.HK](https://longbridge.com/en/quote/02659.HK.md)
- [02575.HK](https://longbridge.com/en/quote/02575.HK.md)
- [01796.HK](https://longbridge.com/en/quote/01796.HK.md)
- [00648.HK](https://longbridge.com/en/quote/00648.HK.md)
- [03321.HK](https://longbridge.com/en/quote/03321.HK.md)
- [08232.HK](https://longbridge.com/en/quote/08232.HK.md)
- [01244.HK](https://longbridge.com/en/quote/01244.HK.md)
- [02476.HK](https://longbridge.com/en/quote/02476.HK.md)
- [00326.HK](https://longbridge.com/en/quote/00326.HK.md)

## Related News & Research

- [Singapore Space & Technology think tank launches Singapore’s first space innovation lab](https://longbridge.com/en/news/286509204.md)
- [Cerebras IPO turns hesitant VC's $270M bet into $5B stake](https://longbridge.com/en/news/286519487.md)
- [Samsung and labor union to meet in 'last chance' to avert strike](https://longbridge.com/en/news/286675762.md)
- [23:36 ETBakery China 2026: Empowering Global Innovation for the Baking Industry](https://longbridge.com/en/news/286849357.md)
- [Xuanzhu Biopharmaceutical Sets March 30 Board Meeting for 2025 Results and Dividend Decision](https://longbridge.com/en/news/279271433.md)